News Overview

Mphasis has allotted 54,728 equity shares under the ESOP and RSU Plan on 12 November 2022. Powered by Capital Market – Live News

The domestic equity indices traded with modest gains in early trade. The Nifty traded above the 18,350 level. Metal, IT and auto shares advanced while pharma, PSU banks and FMCG stocks declined. At 09:22 IST, the barometer index, the S&P BSE Sensex, was up 27.04 points or 0.04% to 61,822.08. The Nifty 50 index gained 20.70 points or 0.11% to 18,370.40. Hindalco (up 3.56%), Power […]

This acquisition opens up a direct-to-consumer practice for HGS.

Hamirpur project EIA report accepted by MOEF.

This growth in turnover shows that the Company has started recovering from the ill effects of Covid-19 pandemic.

Profit before tox (consolidated) stood at Rs28.66 crore in HLFY23 and Rs10.35 crore in Q2FY23.

Ankush will lead Wipro’s business growth in the telecom sector in Southeast Asia.

Copper pulled back slightly in early Asia on Monday, weighed down by regaining strength in dollar overseas. The red metal neared a five month high as dollar dropped to three month low following softer than expected inflation data. Easing inflation figures drove hopes that the US Federal Reserve could ease down its interest rate hike path and boost the metals demand. Sharp rate hikes by […]

A report released by the Labor Department on Thursday showed a modest increase in first-time claims for U.S. unemployment benefits in the week ended November 5th. The Labor Department said initial jobless claims crept up to 225,000, an increase of 7,000 from the previous weeks revised level of 218,000. Meanwhile, the report said the less volatile four-week moving average edged down to 218,750, a decrease […]

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Cyclophosphamide Capsules, 25 mg and 50 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Cyclophosphamide Capsules, 25 mg and 50 mg, of Hikma Pharmaceuticals USA Inc. Cyclophosphamide Capsules is an alkylating drug indicated for the treatment of […]